These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1101 related articles for article (PubMed ID: 28776083)

  • 1. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.
    Jia G; Whaley-Connell A; Sowers JR
    Diabetologia; 2018 Jan; 61(1):21-28. PubMed ID: 28776083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.
    Jia G; DeMarco VG; Sowers JR
    Nat Rev Endocrinol; 2016 Mar; 12(3):144-53. PubMed ID: 26678809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.
    Khan S; Ahmad SS; Kamal MA
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways.
    Lew JK; Pearson JT; Schwenke DO; Katare R
    Cardiovasc Diabetol; 2017 Jan; 16(1):10. PubMed ID: 28086863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
    Jia G; Hill MA; Sowers JR
    Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.
    Falcão-Pires I; Leite-Moreira AF
    Heart Fail Rev; 2012 May; 17(3):325-44. PubMed ID: 21626163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac effects of HDL and its components on diabetic cardiomyopathy.
    Spillmann F; Van Linthout S; Tschöpe C
    Endocr Metab Immune Disord Drug Targets; 2012 Jun; 12(2):132-47. PubMed ID: 22236025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.
    Mandavia CH; Aroor AR; Demarco VG; Sowers JR
    Life Sci; 2013 Mar; 92(11):601-8. PubMed ID: 23147391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic cardiomyopathy and diastolic heart failure -- difficulties with relaxation.
    Teupe C; Rosak C
    Diabetes Res Clin Pract; 2012 Aug; 97(2):185-94. PubMed ID: 22502812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy.
    Dhalla NS; Shah AK; Tappia PS
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic cardiomyopathy.
    Murarka S; Movahed MR
    J Card Fail; 2010 Dec; 16(12):971-9. PubMed ID: 21111987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetic cardiomyopathy].
    Huang YQ; Wang X; Kong W
    Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):31-6. PubMed ID: 21417012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hyperglycaemia in the development of diabetic cardiomyopathy.
    El Hayek MS; Ernande L; Benitah JP; Gomez AM; Pereira L
    Arch Cardiovasc Dis; 2021 Nov; 114(11):748-760. PubMed ID: 34627704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.
    Seferović PM; Paulus WJ
    Eur Heart J; 2015 Jul; 36(27):1718-27, 1727a-1727c. PubMed ID: 25888006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
    Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
    Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat.
    Tate M; Deo M; Cao AH; Hood SG; Huynh K; Kiriazis H; Du XJ; Julius TL; Figtree GA; Dusting GJ; Kaye DM; Ritchie RH
    Diab Vasc Dis Res; 2017 Sep; 14(5):423-433. PubMed ID: 28565941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise Amaliorates Metabolic Disturbances and Oxidative Stress in Diabetic Cardiomyopathy: Possible Underlying Mechanisms.
    Mahmoud AM
    Adv Exp Med Biol; 2017; 999():207-230. PubMed ID: 29022265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies.
    Tarquini R; Pala L; Brancati S; Vannini G; De Cosmo S; Mazzoccoli G; Rotella CM
    Curr Med Chem; 2018; 25(13):1510-1524. PubMed ID: 28685679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on diabetic cardiomyopathy: inches forward, miles to go.
    Tillquist MN; Maddox TM
    Curr Diab Rep; 2012 Jun; 12(3):305-13. PubMed ID: 22528596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.
    Frati G; Schirone L; Chimenti I; Yee D; Biondi-Zoccai G; Volpe M; Sciarretta S
    Cardiovasc Res; 2017 Mar; 113(4):378-388. PubMed ID: 28395009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.